Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PTGX | AZN | AMGN | GILD | VRTX |
| Company | Protagonist Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 113.24 | 175.29 | 337.65 | 124.30 | 455.65 |
| High | 116.57 | 177.43 | 345.11 | 125.17 | 468.18 |
| Low | 113.24 | 175.11 | 337.60 | 123.00 | 453.21 |
| Latest | 115.03 | 176.43 | 344.72 | 124.87 | 466.79 |
| Change | +2.17 | +1.50 | +7.12 | +1.11 | +15.16 |
| % Change | +1.92% | +0.86% | +2.11% | +0.90% | +3.36% |
| Volume | 1,193,600 | 1,489,600 | 2,520,900 | 8,126,300 | 2,034,500 |
| 20-Day Average Volume | 685,735 | 1,972,090 | 3,058,150 | 8,948,285 | 1,427,505 |
| Previous Close | 112.86 | 174.93 | 337.60 | 123.76 | 451.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 103.84 | 181.11 | 341.75 | 128.53 | 443.95 |
| 20-Day Raw Stochastic | 93.53% | 17.99% | 62.00% | 22.01% | 97.11% |
| 20-Day Relative Strength | 62.52 | 42.33 | 51.61 | 42.26 | 60.11 |
| Weighted Alpha | +88.08 | +16.60 | +20.09 | +6.94 | +9.62 |
| Today's Opinion | 100% Buy | 72% Sell | 24% Buy | 72% Sell | 40% Buy |
| Previous Opinion | 100% Buy | 72% Sell | 8% Sell | 72% Sell | 24% Buy |
| Last Month's Opinion | 72% Buy | 8% Buy | 24% Sell | 24% Sell | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.78% since 06/12/26 | -1.30% since 06/12/26 | -2.95% since 06/12/26 | -0.57% since 06/12/26 | +4.91% since 06/12/26 |
| Low | 108.53 on 06/16/26 | 173.65 on 06/18/26 | 334.05 on 06/18/26 | 122.43 on 06/18/26 | 439.50 on 06/15/26 |
| High | 116.57 on 06/22/26 | 180.44 on 06/17/26 | 358.30 on 06/15/26 | 128.20 on 06/17/26 | 468.18 on 06/22/26 |
| 1-Month | |||||
| %Chg | +15.97% since 05/22/26 | -5.67% since 05/22/26 | +1.60% since 05/22/26 | -7.06% since 05/22/26 | +7.43% since 05/22/26 |
| Low | 92.75 on 06/02/26 | 173.65 on 06/18/26 | 322.30 on 06/02/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 116.57 on 06/22/26 | 188.72 on 05/27/26 | 358.46 on 06/11/26 | 137.20 on 05/29/26 | 468.18 on 06/22/26 |
| 3-Month | |||||
| %Chg | +16.34% since 03/20/26 | -3.91% since 03/20/26 | -0.89% since 03/20/26 | -8.99% since 03/20/26 | +2.82% since 03/20/26 |
| Low | 92.75 on 06/02/26 | 173.65 on 06/18/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 116.57 on 06/22/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 468.18 on 06/22/26 |
| 6-Month | |||||
| %Chg | +31.60% since 12/22/25 | -3.64% since 12/22/25 | +4.02% since 12/22/25 | +0.57% since 12/22/25 | +1.41% since 12/22/25 |
| Low | 77.00 on 02/23/26 | 173.65 on 06/18/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 412.27 on 05/05/26 |
| High | 116.57 on 06/22/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 7,258,138 | 271,300,320 | 182,205,424 | 153,656,704 | 114,625,952 |
| Shares Outstanding, K | 64,311 | 1,550,908 | 539,708 | 1,241,570 | 253,805 |
| Annual Sales | 46,020,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -130,150,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 56,370,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 2,986,900,000 |
| Last Quarter Net Income | 3,780,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 1,031,400,000 |
| 60-Month Beta | 1.85 | 0.25 | 0.42 | 0.31 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.05 on 05/05/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 |
| Earnings Date | 08/05/26 | 08/04/26 | 08/04/26 | 08/06/26 | 08/03/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.21 | 15.46 | 14.99 | 27.29 |